BioSpace News Archive

Universal Health Services, Inc., announced that its Board of Directors authorized a $500 million increase to its stock repurchase program.

Bristol-Myers Squibb Company (NYSE:BMY), and Boston Medical Center, a private, not-for-profit, academic medical center, today announced a multi-year joint research study to identify and analyze potential sensitivity and resistance markers in patients treated with standard-of-care checkpoint inhibitors.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter sales and earnings conference call will be broadcast over the Internet on Friday, February 1, 2019, at 8:30 a.m. Eastern Time.

Pulse Biosciences, Inc., announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 17,500 shares of Pulse Biosciences common stock to two new non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on December 15, 2018.

2018 report shows state ranks below national 50th percentile on many quality measures

Pharmco, a brand of Greenfield Global, today announced that they have expanded manufacturing capability for herbal extraction solvents at the company’s Shelbyville, Kentucky, USA facility

SeriousFun Children’s Network has named Justin Fusaro as its new Chief Financial Officer (CFO)

Physicians’ Education Resource® (PER®), the nation’s leading resource for oncology and hematology continuing medical education (CME), announces the full agenda for the 36th Annual Miami Breast Cancer Conference®

Although only an estimated 1% of the US population has celiac disease, millions more, 11% of US households, eat gluten free.

McCann Health agencies were recognized with top honors across the Asia-Pacific region at the Campaign Magazine Asia-Pacific “Agency of The Year Awards” 2018.